FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+8.74%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$19.5B
AUM Growth
+$542M
(+2.9%)
Cap. Flow
-$658M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
40.49%
Holding
567
New
46
Increased
156
Reduced
216
Closed
71
Top Buys
| 1 |
Apple
AAPL
|
$158M |
| 2 |
Microsoft
MSFT
|
$121M |
| 3 |
Home Depot
HD
|
$120M |
| 4 |
Philip Morris
PM
|
$119M |
| 5 |
Johnson Controls International
JCI
|
$114M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$113M |
| 2 |
Verizon
VZ
|
$104M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
$92M |
| 4 |
Aptiv
APTV
|
$88.9M |
| 5 |
Delta Air Lines
DAL
|
$84.3M |
Sector Composition
| 1 | Technology | 21.04% |
| 2 | Healthcare | 19.18% |
| 3 | Communication Services | 17.41% |
| 4 | Consumer Discretionary | 12.02% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
JD.com
JD
$44.6B
| $538K | ﹤0.01% |
20,606
-605
| -3% | -$15.8K |
|
352
VEON
VEON
$3.8B
| $536K | ﹤0.01% |
+6,163
| New | +$536K |
|
|
WFT
353
DELISTED
Weatherford International plc
WFT
| $511K | ﹤0.01% |
90,980
-4,461,055
| -98% | -$25.1M |
|
354
Astria Therapeutics
ATXS
$424M
| $504K | ﹤0.01% |
1,363
-83
| -6% | -$30.7K |
|
|
CVA
355
DELISTED
Covanta Holding Corporation
CVA
| $501K | ﹤0.01% |
32,575
| – | – |
|
356
Clean Harbors
CLH
$12.7B
| $479K | ﹤0.01% |
9,980
| – | – |
|
357
FedEx
FDX
$53.7B
| $474K | ﹤0.01% |
2,716
-2,679
| -50% | -$468K |
|
|
GWPH
358
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $465K | ﹤0.01% |
3,500
+1,250
| +56% | +$166K |
|
359
Illumina
ILMN
$15.7B
| $454K | ﹤0.01% |
+2,570
| New | +$454K |
|
|
DBVT
360
DBV Technologies
DBVT
$245M
| $441K | ﹤0.01% |
1,215
| – | – |
|
|
GBT
361
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $438K | ﹤0.01% |
19,000
+2,000
| +12% | +$46.1K |
|
362
Aecom
ACM
$16.8B
| $434K | ﹤0.01% |
14,585
| – | – |
|
363
Compañía de Minas Buenaventura
BVN
$5.08B
| $409K | ﹤0.01% |
+29,583
| New | +$409K |
|
364
Evolent Health
EVH
$1.11B
| $394K | ﹤0.01% |
16,000
+3,000
| +23% | +$73.9K |
|
365
Ecopetrol
EC
$18.7B
| $386K | ﹤0.01% |
44,044
-12,136
| -22% | -$106K |
|
|
IMOS
366
ChipMOS TECHNOLOGIES
IMOS
$620M
| $378K | ﹤0.01% |
17,307
| – | – |
|
|
TRIL
367
DELISTED
Trillium Therapeutics Inc.
TRIL
| $340K | ﹤0.01% |
+23,000
| New | +$340K |
|
|
RDHL
368
Redhill Biopharma
RDHL
$3.28M
| $299K | ﹤0.01% |
22
+6
| +38% | +$81.5K |
|
369
Exelixis
EXEL
$10.2B
| $294K | ﹤0.01% |
+23,000
| New | +$294K |
|
|
SCTY
370
DELISTED
SolarCity Corporation
SCTY
| $292K | ﹤0.01% |
14,935
| – | – |
|
371
Celldex Therapeutics
CLDX
$1.52B
| $242K | ﹤0.01% |
4,000
+453
| +13% | +$27.4K |
|
|
PETX
372
DELISTED
Aratana Therapeutics, Inc.
PETX
| $234K | ﹤0.01% |
+25,000
| New | +$234K |
|
|
CMRX
373
DELISTED
Chimerix, Inc.
CMRX
| $200K | ﹤0.01% |
36,150
| – | – |
|
374
Regenxbio
RGNX
$490M
| $196K | ﹤0.01% |
14,000
-6,000
| -30% | -$84K |
|
|
FLXN
375
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $195K | ﹤0.01% |
+10,000
| New | +$195K |
|